Talis Biomedical (TLIS)
US Market

Talis Biomedical (TLIS) Financial Statements


Talis Biomedical Financial Overview

Talis Biomedical's market cap is currently ―. The company's EPS TTM is $-47.969; its P/E ratio is -0.12; Talis Biomedical is scheduled to report earnings on November 13, 2023, and the estimated EPS forecast is $-7.37. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--$ 257.00K$ 730.00K$ 502.00K
Gross Profit$ -7.00K$ -20.00K$ -6.89M$ -506.00K$ -800.00K
EBIT$ -15.03M$ -17.83M$ -26.93M$ -26.79M$ -27.27M
EBITDA$ -14.87M$ -17.66M$ -23.37M$ -22.86M$ -26.29M
Net Income Common Stockholders$ -15.03M$ -17.83M$ -26.93M$ -26.02M$ -27.01M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 99.21M$ 113.97M$ 130.19M$ 143.78M$ 165.37M
Total Assets$ 123.08M$ 133.05M$ 169.29M$ 194.09M$ 221.69M
Total Debt$ 20.38M$ 14.71M$ 33.58M$ 33.33M$ 33.10M
Net Debt$ -78.83M$ -99.26M$ -96.61M$ -110.46M$ -132.27M
Total Liabilities$ 26.91M$ 22.93M$ 42.55M$ 41.71M$ 44.67M
Stockholders Equity$ 96.17M$ 110.12M$ 126.74M$ 152.39M$ 177.02M
Cash Flow-
Free Cash Flow$ -14.76M$ -16.49M$ -13.59M$ -21.68M$ -22.21M
Operating Cash Flow$ -14.27M$ -16.46M$ -13.54M$ -20.82M$ -22.01M
Investing Cash Flow$ -485.00K$ -24.00K$ -49.00K$ -860.00K$ -199.00K
Financing Cash Flow-$ 33.00K-$ 92.00K$ 0.00
Currency in USD

Talis Biomedical Earnings and Revenue History

Talis Biomedical Debt to Assets

Talis Biomedical Cash Flow

Talis Biomedical Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis